Companies: 49,246 Total Market Cap: 132441797263938.02

Unité de Fabrication des Médicaments S.A

BVMT-UMED

Pharmaceutical Preparations

Rank #25644

Market Cap 80.77 M

Volume 12,614

Price 2.52

Change (%) 0.53%

Country or region

Tunisia

Unité de Fabrication des Médicaments S.A's latest marketcap:

80.77 M

As of 05/20/2025, Unité de Fabrication des Médicaments S.A's market capitalization has reached $80.77 M. According to our data, Unité de Fabrication des Médicaments S.A is the 25644th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	80.77 M
Revenue (ttm)	47.41 M
Net Income (ttm)	2.16 M
Shares Out	32 M
EPS (ttm)	0
Forward PE	11.38
Ex-Dividend Date	n/a
Earnings Date	05/02/2025

Market Cap Chart

Data Updated: 05/20/2025

Unité de Fabrication des Médicaments S.A's yearly market capitalization.

Unité de Fabrication des Médicaments S.A has seen its market value drop from 312 M TND to 240.32 M TND since 2020, representing a total decrease of 22.97% and an annual compound decline rate (CAGR) of 5.78%.

Date	Market Cap(TND)	Change (%)
05/20/2025	240.32 M	5.05%
12/31/2024	228.16 M	-4.68%
12/29/2023	239.36 M	5.06%
12/30/2022	227.84 M	-3.91%
12/31/2021	237.12 M	-24%
12/31/2020	312 M

Company Profile

About Unité de Fabrication des Médicaments S.A.

Uni té de Fabrication des Médicaments S.A. is a pharmaceutical company specializing in the development, manufacturing, and marketing of generic medicines under the UNIMED brand. Established in 1989, the company operates in Tunisia, Africa, Asia, and Europe.

Key Offerings

Ophthalmic, ENT, and Inhalation Solutions
Infusion Solutions
Injectable Fluids
Penicillin and Cephalosporin Powders
Vaigtaine Products (approximately 40 presentations across various therapeutic classes)

Additional Services

The company also manufactures medicines for third-party laboratory principals, expanding its role in the pharmaceutical supply chain.

Headquarters: Sousse, Tunisia

Frequently Asked Questions

As of 05/20/2025, Unité de Fabrication des Médicaments S.A (including the parent company, if applicable) has an estimated market capitalization of $80.77 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Unité de Fabrication des Médicaments S.A global market capitalization ranking is approximately 25644 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Tunisia
Founded	1989
IPO Date	n/a
Employees	572
CEO	Ridha Charfeddine
Sector
Industry	Pharmaceutical Preparations
Address	Industrial Zone Kalaa Kebira, BP 38 Sousse, 4060 Tunisia
Website	https://www.unimed.com.tn